Literature DB >> 25430952

Autoimmune valvular carditis.

Elise R Breed1, Bryce A Binstadt.   

Abstract

Autoimmune carditis is associated with many human rheumatic conditions, including rheumatic fever, systemic lupus erythematosus, and rheumatoid arthritis. The immune mechanisms that mediate the cardiovascular pathology connected to these diseases are poorly defined. Several animal models are used to recapitulate human pathophysiology in order to better characterize the immunopathogenic mechanisms driving autoimmune endocardial inflammation. These animal models point toward common mechanisms mediating autoimmune endocarditis; in particular, CD4+ T cells and pro-inflammatory macrophages play critical roles in directing the disease process. The goals of this review are to discuss the prevailing animal models of autoimmune endocarditis and their underlying immunologic mechanisms and to provide insight regarding potential therapeutic targets in humans.

Entities:  

Mesh:

Year:  2015        PMID: 25430952      PMCID: PMC4440872          DOI: 10.1007/s11882-014-0491-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  52 in total

1.  Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

2.  Identification of mononuclear cells and T cell subsets in rheumatic valvulitis.

Authors:  E Kemeny; T Grieve; R Marcus; P Sareli; J B Zabriskie
Journal:  Clin Immunol Immunopathol       Date:  1989-08

3.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme.

Authors:  I Matsumoto; A Staub; C Benoist; D Mathis
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

4.  Organ-specific disease provoked by systemic autoimmunity.

Authors:  V Kouskoff; A S Korganow; V Duchatelle; C Degott; C Benoist; D Mathis
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

5.  Cardiovascular death in rheumatoid arthritis: a population-based study.

Authors:  Hilal Maradit-Kremers; Paulo J Nicola; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-03

6.  A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine.

Authors:  A R Shikhman; N S Greenspan; M W Cunningham
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

7.  The mortality of rheumatoid arthritis.

Authors:  F Wolfe; D M Mitchell; J T Sibley; J F Fries; D A Bloch; C A Williams; P W Spitz; M Haga; S M Kleinheksel; M A Cathey
Journal:  Arthritis Rheum       Date:  1994-04

Review 8.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.

Authors:  M Hojnik; J George; L Ziporen; Y Shoenfeld
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

9.  Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.

Authors:  M W Cunningham; S M Antone; J M Gulizia; B M McManus; V A Fischetti; C J Gauntt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity.

Authors:  M W Cunningham; R A Swerlick
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  2 in total

Review 1.  A Review of Cardiac Manifestations in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome With Focus on Endocarditis.

Authors:  Matthew G Tayem; Linda Shahin; John Shook; Marc M Kesselman
Journal:  Cureus       Date:  2022-01-28

Review 2.  Triggers of Inflammatory Heart Disease.

Authors:  Ninaad Lasrado; Bharathi Yalaka; Jay Reddy
Journal:  Front Cell Dev Biol       Date:  2020-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.